Skip Navigation



Carcinogenesis Advance Access published online on August 8, 2007

Carcinogenesis, doi:10.1093/carcin/bgm136
This Article
Right arrow Advance Access manuscript (PDF) Freely available
Right arrow All Versions of this Article:
28/12/2589    most recent
bgm136v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Pandey, J.
Right arrow Articles by Jakowlew, S. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pandey, J.
Right arrow Articles by Jakowlew, S. B.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published by Oxford University Press 2007.

Modulation of tumor induction and progression of oncogenic K-ras positive tumors in the presence of TGF-ß1 haploinsufficiency

Jyotsna Pandey1, Sarah Umphress1, Yang Kang1, Jerry Angdisen1, Alena Naumova1, Kim Mercer2, Tyler Jacks2 and Sonia B. Jakowlew1,3

1 Cell and Cancer Biology Branch, National Cancer Institute, Rockville, MD 20850
2 Massachusetts Institute of Technology, Cambridge, MA 02139

3 Corresponding Author: Sonia B. Jakowlew, PhD, National Cancer Institute, Cell and Cancer Biology Branch, 9610 Medical Center Drive, Suite 300, Rockville, Maryland 20850, Tel 301-594-7280, Fax 301-402-4472, E-Mail: jakowles{at}mail.nih.gov

Oncogenic K-ras is one of the most common genetic alterations in human lung adenocarcinomas. In addition, inactivation of clusters of tumor suppressor genes is required to bring about classical characteristics of cancer including angiogenesis as a prelude to invasion and metastasis. TGF-ß1 is a tumor suppressor gene that is implicated in lung cancer progression. Although in-vitro studies have shown that TGF-ß1 and Ras pathways cooperate during tumorigenesis, the biology of interaction of TGF-ß1 and Ras has not been studied in in-vivo tumorigenesis. We hypothesized that inactivation of TGF-ß1 in addition to oncogeneic activation of K-ras would lead to early initiation and faster progression to lung adenocarcinoma and invasion and metastasis. Heterozygous (HT) TGF-ß1 mice were mated with latent activatable (LA) mutated K-ras mice to generate TGF-ß1+/+, K-ras LA (WT/LA) and TGF-ß1+/-, K-ras LA (HT/LA) mice. Both HT/LA and WT/LA mice developed spontaneous lung tumors, but HT/LA mice progressed to adenocarcinomas significantly earlier compared to WT/LA mice. In addition, WT/LA adenocarcinomas had significantly higher angiogenic activity compared to HT/LA adenocarcinomas. Thus, while oncogenic K-ras mutation and insensitivity to the growth regulatory effects of TGF-ß1 is essential for initiation and progression of mouse lung tumors to adenocarcinoma, a full gene dosage of TGF-ß1 is required for tumor-induced angiogenesis and invasive potential. This study identifies a number of genes not previously associated with lung cancer that are involved in tumor induction and progression. In addition, we provide evidence that progression to invasive angiogenic lesions requires TGF-ß1 responsiveness in addition to Ras mutation.

Key Words: K-ras • TGF-ß • lung tumor • angiogenesis

Received March 1, 2007; revised June 6, 2007; accepted June 10, 2007.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Cancer Res.Home page
K. A. Miller, N. Yeager, K. Baker, X.-H. Liao, S. Refetoff, and A. Di Cristofano
Oncogenic Kras Requires Simultaneous PI3K Signaling to Induce ERK Activation and Transform Thyroid Epithelial Cells In vivo
Cancer Res., April 15, 2009; 69(8): 3689 - 3694.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.